{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:40:07Z","timestamp":1783042807251,"version":"3.54.6"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Stroke"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:p>A polypill-type strategy for primary prevention was first published at the turn of the century and advised that a multi-ingredient pill applied to an adult population would prevent up to 80% of cardiovascular and stroke events. Such a pill should contain small doses of antihypertensives, lipid-lowering drugs, and some nutrients. The startling increase of the global stroke burden has led to a revival of this concept and the propagation of a population-based prevention strategy. Recent cardiovascular fixed-dose combination trials have shown a significant effect in reducing not only blood pressure and cholesterol levels but also in reducing cardiovascular and stroke events. In most of the studies, the study population was for secondary prevention and the total number of strokes was small. Nevertheless, it is now clear that a large proportion of primary prevention must take this path. It is especially promising when combined with community health workers interventions for modifying risk behavior. While a polypill-type approach seems most efficacious in underserved regions of high-income countries as well as in low- and middle-income countries, it seems to have a large overall effect in spite of some problems with nonadherence or potential side effects. It should be available and affordable for large target populations. Larger phase 4 studies are under way.<\/jats:p>","DOI":"10.1161\/strokeaha.122.037313","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T05:00:17Z","timestamp":1655787617000},"page":"2695-2701","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Polypill: Benefits Seen for Stroke and Other Outcomes"],"prefix":"10.1161","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8363-4962","authenticated-orcid":true,"given":"Michael","family":"Brainin","sequence":"first","affiliation":[{"name":"Department for Clinical Neuroscience and Preventive Medicine, University for Continuing Education Krems, Austria (M.B., Y.T.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1755-7943","authenticated-orcid":true,"given":"Yvonne","family":"Teuschl","sequence":"additional","affiliation":[{"name":"Department for Clinical Neuroscience and Preventive Medicine, University for Continuing Education Krems, Austria (M.B., Y.T.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8452-712X","authenticated-orcid":true,"given":"Sheila","family":"Martins","sequence":"additional","affiliation":[{"name":"Neurology and Neurosurgery Service, Hospital Moinhos de Vento, Brazil (S.M.)."},{"name":"Neurology Service, Hospital de Cl\u00ednicas de Porto Alegre, Universidade Federal do Rio Grande do Sul (S.M.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7404.1419"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/14.1.32"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014494"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30141-1"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31752-9"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009868.pub3"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30553-6"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041297"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2010.02412.x"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.277064"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g3318"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/2047487314530382"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31791-X"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028220"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2018-313108"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1177\/2047487317695616"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1600177"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab225"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.030790"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1600175"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1600176"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007174"},{"key":"e_1_3_2_24_2","unstructured":"United States Preventive Services Taskforce: Recommendation: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication Preventive Services Taskforce. Accessed May 18 2022. https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/aspirin-to-prevent-cardiovascular-disease-preventive-medication"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01827-4"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1815359"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31949-X"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00469-9"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(19)30339-0"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(21)00230-9"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1177\/1747493019873706"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12961-020-00553-5"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1717250"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gheart.2019.08.003"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czy099"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-017-0853-y"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.110.592022"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202000236"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2019.04.001"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rceng.2021.05.008"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2021.100872"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.34172\/aim.2021.26"},{"key":"e_1_3_2_43_2","unstructured":"Secondary Prevention of Cardiovascular Disease in the Elderly Trial (SECURE). Accessed May 18 2022. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02596126"},{"key":"e_1_3_2_44_2","unstructured":"INtegrated combination Therapy Electronic General practice support tool phaRmacy led intervention And combination Therapy Evaluation (INTEGRATE). Accessed May 18 2022. https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=370068"},{"key":"e_1_3_2_45_2","unstructured":"Polipill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt in Primary Health Care. Accessed May 18 2022. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05155137"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-018-2564-0"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1177\/1747493018761190"}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/STROKEAHA.122.037313","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:44:56Z","timestamp":1762865096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/STROKEAHA.122.037313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["10.1161\/STROKEAHA.122.037313"],"URL":"https:\/\/doi.org\/10.1161\/strokeaha.122.037313","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"2022-06-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}